Annual FCF
-$79.97 M
+$10.61 M+11.72%
31 December 2023
Summary:
MacroGenics annual free cash flow is currently -$79.97 million, with the most recent change of +$10.61 million (+11.72%) on 31 December 2023. During the last 3 years, it has risen by +$37.84 million (+32.12%). MGNX annual FCF is now -1378.05% below its all-time high of $6.26 million, reached on 31 December 2011.MGNX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$59.57 M
+$105.09 M+230.87%
30 September 2024
Summary:
MacroGenics quarterly free cash flow is currently $59.57 million, with the most recent change of +$105.09 million (+230.87%) on 30 September 2024. Over the past year, it has increased by +$95.31 million (+266.65%). MGNX quarterly FCF is now -41.07% below its all-time high of $101.09 million, reached on 31 December 2017.MGNX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$61.71 M
+$95.31 M+60.70%
30 September 2024
Summary:
MacroGenics TTM free cash flow is currently -$61.71 million, with the most recent change of +$95.31 million (+60.70%) on 30 September 2024. Over the past year, it has dropped by -$39.32 million (-175.67%). MGNX TTM FCF is now -2069.02% below its all-time high of $3.13 million, reached on 30 June 2023.MGNX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGNX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.7% | +266.6% | -175.7% |
| 3 y3 years | +32.1% | +451.9% | +40.3% |
| 5 y5 years | +55.1% | +427.9% | +51.5% |
MGNX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.7% | at high | +200.8% | -2069.0% | +66.1% |
| 5 y | 5 years | at high | +55.1% | at high | +200.8% | -2069.0% | +66.1% |
| alltime | all time | -1378.0% | +55.1% | -41.1% | +194.2% | -2069.0% | +66.1% |
MacroGenics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $59.57 M(-230.9%) | -$61.71 M(-60.7%) |
| June 2024 | - | -$45.52 M(-3.4%) | -$157.02 M(+37.9%) |
| Mar 2024 | - | -$47.10 M(+64.4%) | -$113.88 M(+42.4%) |
| Dec 2023 | -$79.97 M(-11.7%) | -$28.66 M(-19.8%) | -$79.97 M(+257.2%) |
| Sept 2023 | - | -$35.74 M(+1405.1%) | -$22.39 M(-814.3%) |
| June 2023 | - | -$2.38 M(-82.0%) | $3.13 M(-107.0%) |
| Mar 2023 | - | -$13.19 M(-145.6%) | -$44.66 M(-50.7%) |
| Dec 2022 | -$90.58 M(-39.6%) | $28.93 M(-382.9%) | -$90.58 M(-48.3%) |
| Sept 2022 | - | -$10.23 M(-79.6%) | -$175.19 M(-3.7%) |
| June 2022 | - | -$50.17 M(-15.1%) | -$181.90 M(+1.3%) |
| Mar 2022 | - | -$59.11 M(+6.2%) | -$179.48 M(+19.6%) |
| Dec 2021 | -$150.03 M(+27.4%) | -$55.68 M(+228.9%) | -$150.03 M(+45.0%) |
| Sept 2021 | - | -$16.93 M(-64.6%) | -$103.44 M(-8.2%) |
| June 2021 | - | -$47.76 M(+61.0%) | -$112.69 M(+10.4%) |
| Mar 2021 | - | -$29.66 M(+226.2%) | -$102.07 M(-13.4%) |
| Dec 2020 | -$117.80 M(-15.0%) | -$9.09 M(-65.3%) | -$117.80 M(-20.4%) |
| Sept 2020 | - | -$26.18 M(-29.5%) | -$148.00 M(+5.7%) |
| June 2020 | - | -$37.14 M(-18.2%) | -$139.99 M(-8.1%) |
| Mar 2020 | - | -$45.40 M(+15.5%) | -$152.28 M(+9.9%) |
| Dec 2019 | -$138.56 M(-22.2%) | -$39.29 M(+116.3%) | -$138.56 M(+8.9%) |
| Sept 2019 | - | -$18.17 M(-63.2%) | -$127.21 M(-15.3%) |
| June 2019 | - | -$49.42 M(+56.0%) | -$150.24 M(-8.4%) |
| Mar 2019 | - | -$31.68 M(+13.4%) | -$164.05 M(-7.9%) |
| Dec 2018 | -$178.19 M | -$27.94 M(-32.2%) | -$178.19 M(+262.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$41.20 M(-34.9%) | -$49.16 M(-0.0%) |
| June 2018 | - | -$63.23 M(+38.0%) | -$49.17 M(+105.0%) |
| Mar 2018 | - | -$45.81 M(-145.3%) | -$23.99 M(+59.9%) |
| Dec 2017 | -$15.00 M(-72.8%) | $101.09 M(-345.3%) | -$15.00 M(-89.7%) |
| Sept 2017 | - | -$41.20 M(+8.3%) | -$145.48 M(+157.6%) |
| June 2017 | - | -$38.06 M(+3.4%) | -$56.47 M(-1.2%) |
| Mar 2017 | - | -$36.82 M(+25.3%) | -$57.14 M(+3.8%) |
| Dec 2016 | -$55.06 M(+140.9%) | -$29.39 M(-161.5%) | -$55.06 M(+4.7%) |
| Sept 2016 | - | $47.81 M(-223.4%) | -$52.60 M(-52.5%) |
| June 2016 | - | -$38.73 M(+11.5%) | -$110.65 M(+10.4%) |
| Mar 2016 | - | -$34.74 M(+29.0%) | -$100.19 M(+338.3%) |
| Dec 2015 | -$22.86 M(-37.1%) | -$26.93 M(+163.0%) | -$22.86 M(+28.8%) |
| Sept 2015 | - | -$10.24 M(-63.8%) | -$17.75 M(-21.2%) |
| June 2015 | - | -$28.28 M(-166.4%) | -$22.51 M(-2824.7%) |
| Mar 2015 | - | $42.60 M(-295.2%) | $826.00 K(-102.3%) |
| Dec 2014 | -$36.33 M(+112.1%) | -$21.82 M(+45.5%) | -$36.33 M(+118.6%) |
| Sept 2014 | - | -$15.00 M(+203.4%) | -$16.62 M(+744.4%) |
| June 2014 | - | -$4.95 M(-190.9%) | -$1.97 M(-73.5%) |
| Mar 2014 | - | $5.44 M(-358.0%) | -$7.42 M(-56.7%) |
| Dec 2013 | -$17.13 M(+127.8%) | -$2.11 M(+495.5%) | -$17.13 M(+14.0%) |
| Sept 2013 | - | -$354.00 K(-96.6%) | -$15.03 M(+2.4%) |
| June 2013 | - | -$10.40 M(+143.3%) | -$14.67 M(+243.3%) |
| Mar 2013 | - | -$4.27 M | -$4.27 M |
| Dec 2012 | -$7.52 M(-220.2%) | - | - |
| Dec 2011 | $6.26 M | - | - |
FAQ
- What is MacroGenics annual free cash flow?
- What is the all time high annual FCF for MacroGenics?
- What is MacroGenics annual FCF year-on-year change?
- What is MacroGenics quarterly free cash flow?
- What is the all time high quarterly FCF for MacroGenics?
- What is MacroGenics quarterly FCF year-on-year change?
- What is MacroGenics TTM free cash flow?
- What is the all time high TTM FCF for MacroGenics?
- What is MacroGenics TTM FCF year-on-year change?
What is MacroGenics annual free cash flow?
The current annual FCF of MGNX is -$79.97 M
What is the all time high annual FCF for MacroGenics?
MacroGenics all-time high annual free cash flow is $6.26 M
What is MacroGenics annual FCF year-on-year change?
Over the past year, MGNX annual free cash flow has changed by +$10.61 M (+11.72%)
What is MacroGenics quarterly free cash flow?
The current quarterly FCF of MGNX is $59.57 M
What is the all time high quarterly FCF for MacroGenics?
MacroGenics all-time high quarterly free cash flow is $101.09 M
What is MacroGenics quarterly FCF year-on-year change?
Over the past year, MGNX quarterly free cash flow has changed by +$95.31 M (+266.65%)
What is MacroGenics TTM free cash flow?
The current TTM FCF of MGNX is -$61.71 M
What is the all time high TTM FCF for MacroGenics?
MacroGenics all-time high TTM free cash flow is $3.13 M
What is MacroGenics TTM FCF year-on-year change?
Over the past year, MGNX TTM free cash flow has changed by -$39.32 M (-175.67%)